What the Heat needed, based on the composition of the roster heading into the season, was for Terry Rozier to emerge as a dynamic offensive contributor and at least a pest on defense. It largely ...
Viracta Therapeutics is implementing its second round of layoffs in just three months as the cash-strapped biotech tries to keep funds flowing to its lymphoma program. | Viracta Therapeutics is ...